Selected Consolidated Financial Statement Information

6 Months Ended

Dec. 31, 2019

Quarterly Financial Information Disclosure [Abstract]

Selected Consolidated Financial Statement Information

2. Selected Consolidated Financial Statement Information

Accounts Receivable, Net

Accounts receivable consists of the following:

	December 31,		June 30,
	2019		2019
Accounts receivable	$	36,837	$	36,628
Less: Allowance for doubtful accounts	(1,004)		(613)
Accounts receivable, net	$	35,833	$	36,015

Inventories

Inventories consist of the following:

	December 31,		June 30,
	2019		2019
Raw materials	$	7,713	$	5,547
Work in process	2,039		1,415
Finished goods	11,720		11,096
Inventories	$	21,472	$	18,058

Property and Equipment, Net

Property and equipment consists of the following:

	December 31,		June 30,
	2019		2019
Land	$	572	$	572
Building	22,420		22,420
Equipment	18,022		17,517
Furniture	2,981		2,975
Leasehold improvements	563		540
Construction in progress	2,283		1,328
	46,841		45,352
Less: Accumulated depreciation	(19,521)		(18,028)
Property and equipment, net	$	27,320	$	27,324

Accrued Expenses

Accrued expenses consist of the following:

	December 31,		June 30,
	2019		2019
Acquisition consideration	$	9,743	$	—
Commissions	6,920		6,829
Salaries and bonus	6,087		11,105
Accrued vacation	4,870		4,230
Accrued excise, sales and other taxes	2,954		3,349
Clinical studies	2,460		2,092
Other accrued expenses	2,040		1,782
Accrued expenses	$	35,074	$	29,387